Dendreon, a specialty pharma firm, had its stock pop this morning. It soared on news that the firm applied for FDA approval for a prostate cancer vaccine. A different news report highlighted two new "heavy hitter" board members.
Dendreon already had one heavy hitter on the board, Mrs. Susan Bayh, wife of the Indiana Senator. Susan beneficially owns 115,221 shares of Dendreon. At $25 a share, her holdings are valued at nearly $2.9 million.
That could eclipse the Bayh household's take from Susan's WellPoint Board service. Time will tell. Be sure to watch for Senator Evan Bayh's vote on health care reform!
Update 1-12-10: Dendreon's stock is over $30, pushing the Bayhs' holdings to $3.4 million.
No comments:
Post a Comment